Iain B McInnes Selected Research

Musculoskeletal Diseases (Musculoskeletal Disease)

1/2022	Safety of vaccination against SARS-CoV-2 in people with rheumatic and musculoskeletal diseases: results from the EULAR Coronavirus Vaccine (COVAX) physician-reported registry.
10/2021	Message from the new EULAR President and Steering Group.
1/2021	Translational targeting of inflammation and fibrosis in frozen shoulder: Molecular dissection of the T cell/IL-17A axis.
1/2020	Efficacy of tofacitinib in reducing pain in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis.
7/2017	Managing rheumatic and musculoskeletal diseases - past, present and future.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Iain B McInnes Research Topics

Disease

95	Rheumatoid Arthritis 01/2022 - 05/2002
74	Psoriatic Arthritis 07/2022 - 03/2007
59	Inflammation (Inflammations) 06/2022 - 05/2002
43	Arthritis (Polyarthritis) 07/2022 - 12/2002
42	Psoriasis (Pustulosis Palmaris et Plantaris) 06/2022 - 08/2004
27	Necrosis 01/2022 - 01/2006
18	Experimental Arthritis 07/2022 - 12/2002
14	Infections 01/2022 - 02/2003
13	Autoimmune Diseases (Autoimmune Disease) 01/2018 - 02/2003
12	Ankylosing Spondylitis 01/2022 - 01/2016
11	Synovitis 06/2020 - 05/2002
9	Pain (Aches) 01/2022 - 05/2013
9	Rheumatic Diseases (Rheumatism) 10/2021 - 10/2006
9	Tendinopathy (Tendonitis) 01/2021 - 10/2010
7	Joint Diseases (Joint Disease) 01/2022 - 08/2008
6	Atherosclerosis 06/2015 - 02/2008
5	COVID-19 01/2022 - 01/2020
5	Musculoskeletal Diseases (Musculoskeletal Disease) 01/2022 - 07/2017
5	Disease Progression 01/2020 - 12/2007
5	Myocardial Infarction 01/2019 - 01/2010
5	Osteoarthritis 01/2018 - 11/2010
4	Hypoxia (Hypoxemia) 01/2020 - 02/2012
3	Axial Spondyloarthritis 06/2022 - 01/2019
3	Body Weight (Weight, Body) 01/2022 - 09/2010
3	Fatigue 01/2022 - 12/2018
3	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 12/2021 - 01/2019
3	Herpes Zoster 10/2021 - 12/2018
3	Heart Failure 01/2020 - 07/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 09/2013 - 03/2007

Drug/Important Bio-Agent (IBA)

63	CytokinesIBA 01/2022 - 07/2004
25	Biological ProductsIBA 01/2022 - 01/2009
22	secukinumabIBA 06/2022 - 02/2014
20	Interleukin-17 (Interleukin 17)IBA 01/2022 - 11/2007
19	InterleukinsIBA 06/2022 - 08/2004
19	Antirheumatic Agents (DMARD)IBA 01/2022 - 06/2004
18	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2019 - 05/2002
17	Monoclonal AntibodiesIBA 01/2022 - 11/2010
14	LipidsIBA 01/2022 - 05/2005
12	AntigensIBA 07/2022 - 07/2004
12	Interleukin-33IBA 01/2017 - 02/2008
11	C-Reactive ProteinIBA 06/2022 - 08/2013
11	Janus Kinase InhibitorsIBA 01/2022 - 09/2013
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 03/2007
11	Adalimumab (Humira)FDA Link 10/2021 - 07/2010
11	CollagenIBA 01/2021 - 12/2002
11	Ustekinumab (CNTO 1275)FDA Link 11/2019 - 08/2013
11	Interleukin-18 (Interleukin 18)IBA 12/2018 - 01/2003
10	Interleukin-23 (Interleukin 23)IBA 01/2022 - 04/2014
10	guselkumabIBA 01/2022 - 01/2020
10	Tumor Necrosis Factor InhibitorsIBA 10/2021 - 12/2002
10	golimumab FDA Link 01/2020 - 08/2012
10	Methotrexate (Mexate)FDA LinkGeneric 01/2020 - 02/2007
9	tofacitinibIBA 07/2022 - 01/2014
9	Proteins (Proteins, Gene)FDA Link 04/2021 - 07/2004
9	ChemokinesIBA 01/2018 - 07/2008
9	Interleukin-12 (IL 12)IBA 01/2016 - 10/2004
8	AutoantibodiesIBA 04/2021 - 03/2010
8	Interleukin-15 (Interleukin 15)IBA 01/2018 - 05/2002
7	Abatacept (Orencia)FDA Link 07/2020 - 08/2010
6	tocilizumab (atlizumab)FDA Link 01/2022 - 04/2015
6	Interleukin-1 (Interleukin 1)IBA 01/2022 - 10/2004
6	Immunoglobulin G (IgG)IBA 01/2022 - 07/2004
6	AntibodiesIBA 12/2021 - 02/2008
6	Peptides (Polypeptides)IBA 04/2021 - 01/2009
5	Pharmaceutical PreparationsIBA 01/2022 - 02/2007
5	GlucocorticoidsIBA 01/2022 - 12/2018
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 08/2003
5	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020 - 09/2013
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 02/2003
5	CholesterolIBA 01/2019 - 02/2003
5	LigandsIBA 10/2016 - 04/2009
5	Collagen Type II (Type II Collagen)IBA 03/2016 - 01/2009
4	upadacitinibIBA 01/2022 - 01/2020
4	Infliximab (Remicade)FDA Link 01/2020 - 09/2010
4	Etanercept (Enbrel)FDA Link 01/2020 - 01/2016
4	AlarminsIBA 01/2019 - 05/2013
4	mavrilimumabIBA 01/2018 - 09/2013
4	Liver X ReceptorsIBA 06/2017 - 09/2009
4	MicroRNAs (MicroRNA)IBA 06/2017 - 03/2012
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2017 - 10/2011
4	ametantrone (HAQ)IBA 01/2017 - 06/2014
4	Brain Natriuretic Peptide (Natrecor)FDA Link 11/2016 - 07/2010
4	Lipoproteins (Lipoprotein)IBA 10/2016 - 09/2013
3	bimekizumabIBA 07/2022 - 01/2019
3	apremilastIBA 01/2022 - 11/2018
3	baricitinibIBA 01/2022 - 12/2018
3	Type 4 Cyclic Nucleotide PhosphodiesterasesIBA 01/2022 - 06/2011
3	Janus KinasesIBA 01/2022 - 01/2020
3	pro-brain natriuretic peptide (1-76)IBA 01/2020 - 07/2010
3	Sulfasalazine (Azulfidine)FDA LinkGeneric 01/2020 - 02/2007
3	HDL CholesterolIBA 01/2019 - 09/2013
3	ProstaglandinsIBA 01/2017 - 12/2008
3	sphingosine kinaseIBA 01/2017 - 12/2008
3	Anti-Citrullinated Protein AntibodiesIBA 10/2016 - 10/2013
3	Apolipoproteins E (ApoE)IBA 06/2015 - 02/2008
3	Interleukin-10 (Interleukin 10)IBA 01/2015 - 01/2006
3	oxidized low density lipoproteinIBA 01/2015 - 02/2008

Therapy/Procedure

53	Therapeutics 01/2022 - 06/2004
6	Biological Therapy 10/2021 - 10/2006
3	Subcutaneous Injections 01/2020 - 01/2004